Induction of fusion knockdown at an earlier time point before reaching 1% human CD45 in the peripheral blood might have resulted in an eventual exhaustion of T-ALL through differentiation even in the presence of the NRAS mutation but could not be answered in our in vivo experiment conditions where our ethical end point was predetermined. The gene discussed is NRAS; the disease is acute lymphoblastic leukemia.